Pulmonary toxicity of mitomycin
- 15 January 1980
- Vol. 45 (2) , 236-244
- https://doi.org/10.1002/1097-0142(19800115)45:2<236::aid-cncr2820450207>3.0.co;2-0
Abstract
Six patients with breast cancer developed pulmonary toxicity following mitomycin therapy. The presenting symptoms were shortness of breath and a dry cough. The radiological pictures varied from a normal chest x-ray to extensive bilateral pneumonitis. The histological findings consisted of diffuse alveolar damage progressing to interstitial pulmonary fibrosis. Corticosteroid therapy resulted in complete resolution of pneumonia in one patient. Respiratory symptoms improved in 3 patients following discontinuation of the drug. Two patients with extensive bilateral pneumonitis, who were not treated with steriods, died of respiratory failure. Mitomycin-induced lung toxicity appears to be reversible with the discontinuation of drug and the administration of corticosteroids. Lung biopsy is necessary in order to rule out other diagnoses.This publication has 21 references indexed in Scilit:
- Interstitial Pneumonia from MitomycinAnnals of Internal Medicine, 1978
- Procarbazine lungAmerican Journal of Roentgenology, 1978
- Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapyCancer, 1978
- Pulmonary Fibrosis after Prolonged Therapy with 1,3-Bis (2-chloroethyl)-nitrosoureaChest, 1977
- Cytotoxic drug-induced lung diseaseThe American Journal of Medicine, 1977
- Mitomycin C: a reviewCancer Treatment Reviews, 1976
- METHOTREXATE-INDUCED PNEUMONITISMedicine, 1976
- Pulmonary fibrosis following therapy with Melphalan for multiple myelomaJournal of Clinical Pathology, 1972
- Experience in Monitoring Drug Reactions in OutpatientsPublished by American Medical Association (AMA) ,1971
- Lung Changes and Chemotherapeutic Agents in ChildhoodAmerican Journal of Diseases of Children, 1970